UK NICE to Announce Decision on Vertex’s Therapy Trikafta in December
The National Institute for Health and Care Excellence (NICE) in the U.K. is currently in the process of evaluating Vertex...
FDA Grants Fast Track Status to Translate Bio’s RNA-Based Therapy MRT5005
The U.S. Food and Drug Administration (FDA) has granted fast track designation to MRT5005, an investigational RNA-based treatment for...
Vertex Announces Availability of Cystic Fibrosis Medicine KALYDECO® (ivacaftor) in New Zealand
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that KALYDECO® (ivacaftor) will be available to eligible patients with...
Arch Scientist Publishes Data on the Pre-Clinical Efficacy of AB569 in Killing of Drug Resistant Bac
TORONTO, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., ("Arch" or the "Company") (TSXV:ARCH, OTCQB:ACHFF), announced today...
Cystic Fibrosis And Infertility
Although, cystic fibrosis does not have any permanent,-cure, prevention can reduce the severity of complications Cystic fibrosis is a...
How cystic fibrosis can manifest in the gastrointestinal system
In the February 2020 issue of Contemporary Pediatrics, Drs. Anna Reed and Darla Shores provide a briefing on the care of cystic fibrosis...
New X-Ray Technology For Better Management Of Lung Diseases
Australia: Researchers at Monash University have developed radical non-invasive X-ray technology to help diagnose, treat and manage...
Noninvasive XV Technology May Lead to Faster CF Diagnosis and Better Treatment
A new non-invasive tool, called XV technology, allows professionals to visualize airflow in a living lungs and could help in the...
Arrevus Receives FDA Orphan Drug Designation for ARV-1801 (sodium fusidate)
Arrevus, a clinical stage biopharmaceutical company committed to the development of innovative therapies to treat orphan or serious...
Synspira Therapeutics, CF Foundation Agree to Support Development of SNSP003 for Malabsorption Syndr
The Cystic Fibrosis Foundation has reached an agreement with Synspira Therapeutics to support the further development of SNSP003, an...
